Today's hospital pharmacy administrators are faced with multiple interconnected challenges1,2:
BD Cato™ Medication Workflow Solutions is a software system that was developed to advance the process of IV compounding. With its real-time gravimetric and bar code verification—in tandem with a step-by-step guidance system—BD Cato™ is designed to simultaneously minimize errors while improving efficiency.
Medication Safety—Designed to minimize probability of errors in IV compounding through a combination of gravimetrics and bar code verification
Workflow Efficiency—Standardizes workflow and enables pharmacists to eliminate redundant steps to help
Inventory Optimization—Helps reduce waste by optimizing use of drugs in the preparation of IV admixtures
Documentation, Compliance, and Analytics—Documents every step to enable compliance and leverages data analytics to monitor productivity in the clean room
Support for the use of gravimetrics is gaining momentum
BD Cato™ Medication Workflow Solutions is designed to minimize the probability of errors in IV compounding through the use of an interactive display, bar code scanner, and gravimetric scale.
BD Cato™ Medication Workflow Solutions can help you improve your pharmacy's workflow efficiency in various ways:
BD Cato™ Medication Workflow Solutions provides automated data capture that enables documentation, compliance, and production analytics.
*All admixtures prepared using gravimetric verification. Total estimated preparations, as of 9/30/14.
References: 1. ASHP Strategic Plan. Bethesda, MD: American Society of Health-System Pharmacists; 2013. 2. Pharmacy Automation: Technologies and Global Markets. Wellesley, MA: BCC Research; March 2014. Report IAS026D. 3. Flynn EA, Pearson RE, Barker KN. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health Syst Pharm. 1997;54(8):904-912. 4. Poppe LB, Savage SW, Eckel SF. Assessment of final product dosing accuracy when using volumetric technique in the preparation of chemotherapy [published online ahead of print September 2, 2014]. J Oncol Pharm Pract. doi:10.1177/1078155214549489. 5. American Society of Health-System Pharmacists. ASHP guidelines on the safe use of automated compounding devices for the preparation of parenteral nutrition admixtures. Am J Health Syst Pharm. 2000;57(14): 1343-1348. 6. The United States Pharmacopeial Convention. <797> pharmaceutical compounding—sterile preparations. 2008. http://www.pbm.va.gov/linksotherresources/docs/USP797PharmaceuticalCompoundingSterileCompounding.pdf. Accessed November 17, 2014. 7. Institute for Safe Medication Practices. Proceedings from the ISMP Sterile Preparation Compounding Safety Summit: guidelines for SAFE preparation of sterile compounds. 2013. http://www.ismp.org/tools/guidelines/IVSummit/IVCGuidelines.pdf. Accessed November 17, 2014. 8. Institute for Safe Medication Practices. Tragic error with neuromuscular blocker should prompt risk assessment by all hospitals. http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=97. Accessed February 12, 2015. 9. Data on file. BD.